These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 32867211)

  • 1. Specific Receptors for the Chemokines CXCR2 and CXCR4 in Pancreatic Cancer.
    Litman-Zawadzka A; Łukaszewicz-Zając M; Gryko M; Kulczyńska-Przybik A; Kędra B; Mroczko B
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32867211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum chemokine CXCL8 as a better biomarker for diagnosis and prediction of pancreatic cancer than its specific receptor CXCR2, C-reactive protein, and classic tumor markers CA 19-9 and CEA.
    Litman-Zawadzka A; Łukaszewicz-Zając M; Gryko M; Kulczyńska-Przybik A; Mroczko B
    Pol Arch Intern Med; 2018 Sep; 128(9):524-531. PubMed ID: 30057378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum concentrations of receptor for interleukin 8 in patients with esophageal cancer.
    Łukaszewicz-Zając M; Kulczyńska-Przybik A; Muszyński P; Kozłowski M; Szmitkowski M; Mroczko B
    Pol Arch Med Wewn; 2016 Oct; 126(11):854-861. PubMed ID: 27906878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Clinical Utility of Serum CXCR-2 Assessment in Colorectal Cancer (CRC) Patients.
    Pączek S; Łukaszewicz-Zając M; Gryko M; Kulczyńska-Przybik A; Mroczko B
    Anticancer Res; 2021 Mar; 41(3):1421-1428. PubMed ID: 33788733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic usefulness of serum interleukin 6 (IL-6) and C-reactive protein (CRP) in the differentiation between pancreatic cancer and chronic pancreatitis.
    Mroczko B; Groblewska M; Gryko M; Kedra B; Szmitkowski M
    J Clin Lab Anal; 2010; 24(4):256-61. PubMed ID: 20626020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Serum Concentrations of Chemokine CXCL12 and Its Specific Receptor CXCR4 in Patients with Esophageal Cancer.
    Łukaszewicz-Zając M; Mroczko B; Kozłowski M; Szmitkowski M
    Dis Markers; 2016; 2016():7963895. PubMed ID: 27041792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A positive crosstalk between CXCR4 and CXCR2 promotes gastric cancer metastasis.
    Xiang Z; Zhou ZJ; Xia GK; Zhang XH; Wei ZW; Zhu JT; Yu J; Chen W; He Y; Schwarz RE; Brekken RA; Awasthi N; Zhang CH
    Oncogene; 2017 Sep; 36(36):5122-5133. PubMed ID: 28481874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum dickkopf-1 is a novel serological biomarker for the diagnosis and prognosis of pancreatic cancer.
    Han SX; Zhou X; Sui X; He CC; Cai MJ; Ma JL; Zhang YY; Zhou CY; Ma CX; Varela-Ramirez A; Zhu Q
    Oncotarget; 2015 Aug; 6(23):19907-17. PubMed ID: 26101916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Verification of the effectiveness of fucosylated haptoglobin as a pancreatic cancer marker in clinical diagnosis.
    Kuwatani M; Kawakami H; Kubota Y; Kawakubo K; Ito YM; Togo S; Ikeda T; Kusama K; Kobayashi Y; Murata T; Sakamoto N
    Pancreatology; 2019 Jun; 19(4):569-577. PubMed ID: 31031206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ERCP combined with tumor markers in differential diagnosis of pancreatic cancer and pseudotumor-like pancreatitis.
    Luo B; Peng F; Hong M; Su S; Fang C; Yang X; Xia G; Li B
    J BUON; 2019; 24(4):1568-1573. PubMed ID: 31646810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Circulating MiR-25 as a Potential Biomarker for Pancreatic Cancer Diagnosis.
    Deng T; Yuan Y; Zhang C; Zhang C; Yao W; Wang C; Liu R; Ba Y
    Cell Physiol Biochem; 2016; 39(5):1716-1722. PubMed ID: 27639768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applicative Value of Serum CA19-9, CEA, CA125 and CA242 in Diagnosis and Prognosis for Patients with Pancreatic Cancer Treated by Concurrent Chemoradiotherapy.
    Gu YL; Lan C; Pei H; Yang SN; Liu YF; Xiao LL
    Asian Pac J Cancer Prev; 2015; 16(15):6569-73. PubMed ID: 26434876
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel multiplex-protein array for serum diagnostics of colon cancer: a case-control study.
    Bünger S; Haug U; Kelly M; Posorski N; Klempt-Giessing K; Cartwright A; Fitzgerald SP; Toner V; McAleer D; Gemoll T; Laubert T; Büning J; Fellermann K; Bruch HP; Roblick UJ; Brenner H; von Eggeling F; Habermann JK
    BMC Cancer; 2012 Sep; 12():393. PubMed ID: 22954206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage inhibitory cytokine-1/growth differentiation factor-15 in premalignant and neoplastic tumours in a high-risk pancreatic cancer cohort.
    O'Neill RS; Emmanuel S; Williams D; Stoita A
    World J Gastroenterol; 2020 Apr; 26(14):1660-1673. PubMed ID: 32327914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Usefulness of the SCC, CEA, CYFRA 21.1, and CRP markers for the diagnosis and monitoring of cervical squamous cell carcinoma].
    Chmura A; Wojcieszek A; Mrochem J; Walaszek-Gruszka A; Deja R; Masłyk B; Bartnik W; Sodowski K
    Ginekol Pol; 2009 May; 80(5):361-6. PubMed ID: 19548456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCL-8 in Preoperative Colorectal Cancer Patients: Significance for Diagnosis and Cancer Progression.
    Pączek S; Łukaszewicz-Zając M; Gryko M; Mroczko P; Kulczyńska-Przybik A; Mroczko B
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32192002
    [No Abstract]   [Full Text] [Related]  

  • 17. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer.
    Ni XG; Bai XF; Mao YL; Shao YF; Wu JX; Shan Y; Wang CF; Wang J; Tian YT; Liu Q; Xu DK; Zhao P
    Eur J Surg Oncol; 2005 Mar; 31(2):164-9. PubMed ID: 15698733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of the tumor markers CA 19-9 and carcinoembryonic antigen (CEA) in diagnosis, treatment and prognosis of pancreatic cancer].
    Kokhanenko NIu; Ignashov AM; Varga EV; Polkanova MS; Aleshina LA; Kimbarovskaia AA; Osipenko SK; Lebedev EG
    Vopr Onkol; 2001; 47(3):294-7. PubMed ID: 11544826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression of chemokine receptors CCR6, CXCR2 and CXCR4 is not organ-specific for distant metastasis in colorectal cancer: a comparative study.
    Hu D; Du C; Xue W; Dou F; Yao Y; Gu J
    Histopathology; 2013 Aug; 63(2):167-73. PubMed ID: 23758411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum tumor markers not useful in screening patients with pancreatic mucinous cystic lesions associated with malignant changes.
    Pezzilli R; Calculli L; Melzi d'Eril G; Barassi A
    Hepatobiliary Pancreat Dis Int; 2016 Oct; 15(5):553-557. PubMed ID: 27733327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.